Khalil Barrage

Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ.

Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA.

Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.

The Invus Group LLC is an Independent Venture Capital firm founded in 1985 by Raymond Debbane. The Invus Group LLC is headquartered in New York, US with additional office in Paris.

Invus Public Equities Advisors LLC is an investment advisory firm headquartered in New York City. The firm was founded by Raymond Debbane in 1985 and is a subsidiary of The Invus Group LLC. Invus Public Equities Advisors serves as the general partner of Invus Public Equities, L.P.

The Olayan Group operates as a diversified enterprise that engages in trading, manufacturing, services and investments sectors. It manages commercial and industrial operations in Saudi Arabia through its subsidiary Olayan Financing Company. The firm’s investment team focuses on public and private equities, real estate, fixed income securities, and other specialized assets. It operates through its offices located in Europe, Saudi Arabia and the United States. The company was founded by Suliman S. Olayan in 1947 and is headquartered in Riyadh, Saudi Arabia.